Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - losartanum kalíum - filmuhúðuð tafla - 100 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - losartanum kalíum - filmuhúðuð tafla - 50 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Den europeiske union - islandsk - EMA (European Medicines Agency)

baxter holding b.v. - doxórúbicín hýdróklóríð - sarcoma, kaposi; multiple myeloma; ovarian neoplasms; breast neoplasms - Æxlishemjandi lyf - einungis mjög liposomal er ætlað:eitt og sér fyrir sjúklinga með brjóstakrabbamein, þar sem það er aukin hjarta hættu;fyrir meðferð háþróaður krabbamein í konum sem hafa mistekist fyrsta lína platínu-byggt lyfjameðferð meðferð;ásamt bortezomib fyrir meðferð framsækið margar forráðamenn í sjúklingar sem hafa fengið að minnsta kosti einn áður en meðferð og hver hefur þegar tekið eða eru ekki við hæfi fyrir beinmerg grætt;fyrir meðferð aids-tengjast kaposissarkmein (ksxp) í sjúklinga með litla cd4 telja (.

Den europeiske union - islandsk - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doxórúbicín hýdróklóríð - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Æxlishemjandi lyf - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 300 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 75 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 225 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - gabapentinum inn - filmuhúðuð tafla - 600 mg